AKT1 and neoplasm: Notwithstanding the transcriptional regulation, FXR can also modulate a variety of cell signaling pathways, such as PI3K/Akt, MEK/Erk1/2, Jak/STAT, and Wnt/β-catenin in tumor cells (33).